Research progress in diagnosis and treatment of hepatorenal syndrome
CSTR:
Author:
Affiliation:

(Department of Nephrology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China)

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Hepatorenal syndrome (HRS) is a severe complication of advanced liver disease, and manifests as oliguria or anuria, hypoxemia, hyponatremia and low urine sodium, but shows no obviously pathological changes of renal damage. Its diagnosis need to exclude other reasons of renal injury. The onset was associated with hepatic dysfunction, portal hypertension, impaired blood volume and renal vasoconstriction. Based upon the rapid deterioration in kidney function, it is classified into 2 types. Therapeutic effect of vasoconstrictor drugs (terlipressin) plus albumin infusion is satisfactory, and liver transplantation is the best option for patients with end stage liver failure.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:March 16,2017
  • Revised:April 17,2017
  • Adopted:
  • Online: August 25,2017
  • Published:
Article QR Code